Insider Transactions Reported by 10 Insiders of Benitec Biopharma Inc.

Symbol
BNTC on Nasdaq
Location
Hayward, CA

Insiders trading volume in the past year

Benitec Biopharma Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10%+ Owner $24,839,216 +$34,353,835 23 Dec 2025
Steven Michael Oliveira 10%+ Owner $3,044,300 28 Apr 2021
J. Kevin Buchi Director $401,092 01 Dec 2025
Sophie Mukadam Chief Operating Officer $67,680 18 Nov 2025
Megan Boston Chief Financial Officer, Director 18 Nov 2025
Sharon Mates Director 22 Jan 2026
Peter Francis Director 01 Dec 2025
Kishan Mehta Director 01 Dec 2025
Edward F. Smith Director 01 Dec 2025
Jerel A. Banks Chief Executive Officer, Director 18 Nov 2025

Recent Insider Transactions by Companies or Individuals for Benitec Biopharma Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Sharon Mates BNTC Options (right to buy) Award 31,500 31,500 22 Jan 2026 Direct
Suvretta Capital Management, Llc BNTC Common stock, par value $0.0001 per share Purchase 0.8% $1,040,081 $13.44 77,387 9,700,195 29 Dec 2025 See footnotes
Suvretta Capital Management, Llc BNTC Common stock, par value $0.0001 per share Purchase 0.18% $220,552 $13.10 16,836 9,634,395 26 Dec 2025 See footnotes
Suvretta Capital Management, Llc BNTC Common stock, par value $0.0001 per share Purchase 0.52% $642,500 $12.85 50,000 9,620,075 23 Dec 2025 See footnotes
Suvretta Capital Management, Llc BNTC Common stock, par value $0.0001 per share Purchase 0.2% $236,067 $12.08 19,542 9,577,475 22 Dec 2025 See footnotes
Suvretta Capital Management, Llc BNTC Common stock, par value $0.0001 per share Purchase 0.17% $188,088 $11.48 16,384 9,560,825 19 Dec 2025 See footnotes
Suvretta Capital Management, Llc BNTC Common stock, par value $0.0001 per share Purchase 0.11% $114,817 $11.24 10,215 9,546,875 18 Dec 2025 See footnotes
Sharon Mates BNTC Options (right to buy) Award 3,500 3,500 01 Dec 2025 Direct
Kishan Mehta BNTC Options (right to buy) Award 35,000 35,000 01 Dec 2025 Direct
Edward F. Smith BNTC Options (right to buy) Award 35,000 35,000 01 Dec 2025 Direct
Peter Francis BNTC Options (right to buy) Award 35,000 35,000 01 Dec 2025 Direct
J. Kevin Buchi BNTC Options (right to buy) Award 35,000 35,000 01 Dec 2025 Direct
Sophie Mukadam BNTC Options (right to buy) Award 500,000 500,000 18 Nov 2025 Direct
Jerel A. Banks BNTC Options (right to buy) Award 450,000 450,000 18 Nov 2025 Direct
Megan Boston BNTC Options (right to buy) Award 200,000 200,000 18 Nov 2025 Direct
Suvretta Capital Management, Llc BNTC Common stock, par value $0.0001 per share Purchase 18.4% $19,999,994 $13.50 1,481,481 9,538,175 07 Nov 2025 See footnotes
Sharon Mates BNTC Options (right to buy) Award 28,517 28,517 05 Nov 2025 Direct
Suvretta Capital Management, Llc BNTC Common stock, par value $0.0001 per share Purchase 0.19% $211,736 $12.83 16,497 8,807,805 31 Mar 2025 See footnotes
Suvretta Capital Management, Llc BNTC Common stock, par value $0.0001 per share Purchase 11.4% $11,700,000 $13.00 900,000 8,793,245 26 Mar 2025 See footnotes
* An asterisk sign (*) next to the price indicates that the price is likely invalid.